FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+26.49%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$988M
AUM Growth
+$988M
(+15%)
Cap. Flow
+$522K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
77
New
6
Increased
26
Reduced
14
Closed
6
Top Buys
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$26.5M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$9.11M |
| 3 |
Transmedics
TMDX
|
$6.42M |
| 4 |
Direxion Daily S&P Biotech Bull 3X Shares
LABU
|
$6.01M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
$5.15M |
Top Sells
| 1 |
Prothena Corp
PRTA
|
$24.2M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$10.6M |
| 3 |
Krystal Biotech
KRYS
|
$7.18M |
| 4 |
Codexis
CDXS
|
$7.17M |
| 5 |
MODN
MODEL N, INC.
MODN
|
$4.98M |
Sector Composition
| 1 | Healthcare | 86.29% |
| 2 | Communication Services | 9.04% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Prothena Corp
PRTA
$441M
| $93.3M | 9.44% | 1,538,678 -399,505 | -21% | -$24.2M |
|
|
MODN
2
DELISTED
MODEL N, INC.
MODN
| $89.3M | 9.04% | 2,608,221 -145,537 | -5% | -$4.98M |
|
3
AtriCure
ATRC
$1.84B
| $58.4M | 5.91% | 1,494,655 +15,029 | +1% | +$588K |
|
|
SPNE
4
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $40.1M | 4.06% | 7,067,572 +37,263 | +0.5% | +$212K |
|
|
KRTX
5
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $37.4M | 3.79% | 166,316 +40,523 | +32% | +$9.11M |
|
6
Halozyme
HALO
$8.56B
| $36.9M | 3.73% | 932,244 -9,001 | -1% | -$356K |
|
7
SI-BONE Inc
SIBN
$719M
| $35.4M | 3.58% | 2,027,963 +21,659 | +1% | +$378K |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $34.8M | 3.52% | 763,180 -8,634 | -1% | -$394K |
|
9
Axogen
AXGN
$743M
| $34.7M | 3.51% | 2,911,824 -113,295 | -4% | -$1.35M |
|
|
10
Krystal Biotech
KRYS
$4.27B
| $34.3M | 3.47% | 492,555 -103,057 | -17% | -$7.18M |
|
11
Omnicell
OMCL
$1.5B
| $30.4M | 3.07% | 349,106 +2,077 | +0.6% | +$181K |
|
|
RETA
12
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $26.5M | 2.68% | +1,054,985 | New | +$26.5M |
|
13
Crinetics Pharmaceuticals
CRNX
$2.92B
| $26.4M | 2.68% | 1,346,652 +106,043 | +9% | +$2.08M |
|
14
Alphatec Holdings
ATEC
$2.35B
| $26M | 2.63% | 2,974,658 +49,694 | +2% | +$434K |
|
|
BLU
15
DELISTED
BELLUS Health Inc.
BLU
| $25.2M | 2.55% | 2,381,857 -26,217 | -1% | -$277K |
|
16
NeoGenomics
NEO
$1.13B
| $23.4M | 2.37% | 2,720,099 +4,612 | +0.2% | +$39.7K |
|
17
Tandem Diabetes Care
TNDM
$845M
| $23.2M | 2.35% | 485,620 +18,065 | +4% | +$864K |
|
18
Keros Therapeutics
KROS
$618M
| $22.5M | 2.28% | 598,213 -120 | -0% | -$4.51K |
|
|
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
| $22.3M | 2.26% | 316,809 +2,805 | +0.9% | +$198K |
|
|
FNA
20
DELISTED
Paragon 28, Inc.
FNA
| $22.1M | 2.23% | 1,238,055 +544 | +0% | +$9.69K |
|
21
Pliant Therapeutics
PLRX
$101M
| $20.2M | 2.04% | 965,114 +195,744 | +25% | +$4.09M |
|
22
Ultragenyx Pharmaceutical
RARE
$2.89B
| $18.8M | 1.9% | 453,794 +1,324 | +0.3% | +$54.8K |
|
|
BCYC
23
Bicycle Therapeutics
BCYC
$511M
| $16.4M | 1.66% | 704,721 +439 | +0.1% | +$10.2K |
|
24
Insmed
INSM
$28.8B
| $16.3M | 1.65% | 756,417 -5,765 | -0.8% | -$124K |
|
25
OrthoPediatrics
KIDS
$536M
| $14.2M | 1.44% | 308,728 -5,996 | -2% | -$277K |
|